This allows your body to adjust, often reducing nausea risk
4 Tumilty L, Davison G, Beckmann M, Thatcher R
We offer treatments that not only focus on shedding pounds but also prioritize your overall health, metabolism, and long-term well-being
A provider may suggest adjusting your dose or using over-the-counter aids to help manage the transition
It is added because it addresses two specific and significant clinical problems that arise from GLP-1 receptor agonist therapy: nausea at treatment initiation and progressive B12 depletion over the course of long-term use
The Semaglutide Patent Puzzle: Evergreening and the Uphill Battle for Indian Generics Post-2026 Semaglutide, Novo Nordisks blockbuster GLP-1 receptor agonist marketed as Ozempic and Wegovy, has revolutionized the management of type 2 diabetes and obesity